Neuropediatrics 2023; 54(01): 037-043
DOI: 10.1055/a-1942-2447
Original Article

Efficacy, Retention Rate, and Influencing Factors of Ketogenic Diet Therapy in Children with Refractory Epilepsy: A Retrospective Study

1   Department of Neurology, Children's Hospital, School of Medicine, Zhejiang University, Hangzhou, China
,
1   Department of Neurology, Children's Hospital, School of Medicine, Zhejiang University, Hangzhou, China
,
Feng Gao
1   Department of Neurology, Children's Hospital, School of Medicine, Zhejiang University, Hangzhou, China
,
2   Department of Biobank, Children's Hospital, School of Medicine, Zhejiang University, Hangzhou, China
3   Department of Neurobiology, Key Laboratory of Medical Neurobiology of Ministry of Health of China, Zhejiang Province Key Laboratory of Neurobiology, School of Medicine, Zhejiang University, Hangzhou, China
› Author Affiliations

Funding This study was supported by a Grant from the Zhejiang Provincial Education Department Foundation of China (Y201737746).
Preview

Abstract

Background This study aimed to evaluate the efficacy and retention rate of a ketogenic diet (KD) and assess factors that influence the efficacy of KD therapy in children with refractory epilepsy (RE).

Methods We retrospectively studied the efficacy and retention rate of 56 RE children who accepted KD therapy from January 2013 to December 2019. Patients who had a ≥50% reduction in seizure frequency were defined as responders. The retention rate was calculated as the proportion of children who continued KD/the total number of children who were followed up at the time of enrollment. We also analyzed the effects of different factors (such as gender, KD initial age, KD duration, the type of epilepsy syndrome, and others) on the efficacy of the KD.

Results (1) The efficacy rates for the KD at 3, 6, 12, and 18 months were 51.8, 53.6, 39.2, and 23.2%, respectively. (2) The retention rates for the KD at 3, 6, 12 and 18 months were 100, 69.6, 41.1, and 23.2%, respectively. (3) There was no correlation between efficacy and gender, epilepsy onset age, the type of epilepsy syndrome, electroencephalogram improvement, or the number of antiseizure medications, while cranial magnetic resonance imaging (MRI) abnormalities, KD duration, and KD initial age affected its efficacy at 3 months.

Conclusion (1) KD therapy for refractory childhood epilepsy was effective and produced a high retention rate. (2) MRI abnormalities and the initial age and duration of KD influenced its short-term efficacy in RE children.



Publication History

Received: 25 April 2022

Accepted: 08 September 2022

Accepted Manuscript online:
13 September 2022

Article published online:
21 December 2022

© 2022. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany